Alamar Biosciences Expects 2026 Revenue of $121M-$123M
Alamar Biosciences expects 2026 revenue of $121 million to $123 million; FactSet estimates $118.6 million.
Related stories
Spartan Delta Q3 Oil and Gas Sales C$202.617 Million
M impact | EARNINGS | Nov 03, 2026, 11:04 PM UTC
Amdocs Sees First-Quarter Adjusted EPS of $1.27–$1.33
M impact | EARNINGS | Nov 03, 2026, 11:04 PM UTC
Amdocs Sees First-Quarter Revenue at $955M-$995M
M impact | EARNINGS | Nov 03, 2026, 11:03 PM UTC
Spartan Delta Reports Q3 Net Income of CAD 4.04 Million
M impact | EARNINGS | Nov 03, 2026, 11:03 PM UTC
ISA Energia Reports Strong Profit Rise on Accounting Effect
ISA Energia’s profit rose sharply due to an accounting effect; the company is cautious about auctions.
M impact | EARNINGS | Nov 03, 2026, 11:03 PM UTC
Alamar Biosciences Raises 2026 Revenue Guidance to $121M–$123M
The company’s full-year 2026 revenue outlook is above the FactSet consensus estimate of $118.6 million.
M impact | EARNINGS | Nov 03, 2026, 11:03 PM UTC